Response to External Radiation and Interstitial Brachytherapy in Bulky Vulvar Cancer

I.A.Trisna Kumala Dewi, Sri Mutya Sekarutami

Sari


Vulvar cancer is a gynaecologic malignancy with an incidence of 3-5% of all gynaecologic malignancies. In Indonesia, number of new cases of vulvar cancer reaches 1153 cases with a mortality rate of 420. Multimodal therapy is the main therapy of vulvar cancer at advanced stage which consists of of surgery, radiotherapy, and chemotherapy. The role of brachytherapy as adjunctive therapy combined with EBRT is widely studied, especially its role in the management of patients with comorbidities or contraindications to surgery. The purpose of writing this case report is to assess the response of radiotherapy in the form of external beam radiotherapy (EBRT) and brachytherapy use the MUPIT applicator in patients with vulvar cancer. From the relevant studies, we obtain a good 5-year overall survival rate, disease free survival rate, and local control with tolerable complications. It can be concluded that the combination of EBRT and brachytherapy can be one of the therapeutic modality of choice in vulvar cancer.


Kata Kunci


vulvar cancer, radiotherapy, brachytherapy, MUPIT, response of radiotherapy in vulvar cancer

Teks Lengkap:

PDF (English)

Referensi


Chapman BV, Gill BS, Viswanathan AN, Balasubramani GK, Sukumvanich P, Beriwal S. Adjuvant Radiation Therapy for Margin-Positive Vulvar Squamous Cell Carcinoma: Defining the Ideal Dose-Response Using the National Cancer Data Base. International Journal of Radiation Oncology*Biology*Physics. 2017 Jan;97(1):107–17.

Hacker NF, Eifel PJ, van der Velden J. Cancer of the vulva. International Journal of Gynecology & Obstetrics. 2015 Oct;131:S76–83.

Indonesia - Global Cancer Observatory. IARC; 2018.

Rao YJ, Hui C, Chundury A, Schwarz JK, DeWees T, Powell MA, et al. Which patients with inoperable vulvar cancer may benefit from brachytherapy in addition to external beam radiation? A Surveillance, Epidemiology, and End Results analysis. Brachytherapy. 2017 Jul;16(4):831–40.

Xanthopoulos EP, Grover S, Puri PM, Corradetti MN, Heilbroner SP, Mitra N, et al. Survival Benefit of Adjuvant Radiation Therapy in Node-positive Vulvar Cancer: American Journal of Clinical Oncology. 2018 Sep;41(9):845–50.

Alkatout I, Günther V, Schubert M, Weigel M, Garbrecht N, Jonat W, et al. Vulvar cancer: epidemiology, clinical presentation, and management options. IJWH. 2015 Mar;305.

Hoffman BL, Schorge JO, Bradshaw KD, Halvorson LM, Schaffer JI, Corton MM. Williams gynecology. 2016.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018: Cancer Statistics, 2018. CA: A Cancer Journal for Clinicians. 2018 Jan;68(1):7–30.

Koh W-J, Riaz N, Bean S, Bradley K, Campos S, Cho K, et al. Vulvar cancer (squamous cell carcinoma). 2nd ed. NCCN; 2018.

Fuh KC, Berek JS. Current Management of Vulvar Cancer. Hematology/Oncology Clinics of North America. 2012 Feb;26(1):45–62.

Bansal I, Panda D, Rathi A, Anand A, Bansal A. Rationale, indications, techniques and applications of interstitial brachytherapy for carcinoma cervix. Asian Journal of Oncology. 2016 Jul;02(02):069–78.

Hughes KE, McLaughlin CM, Fields EC. High-Dose Rate Salvage Interstitial Brachytherapy: A Case-Based Guide to the Treatment of Therapeutically Challenging Recurrent Vulvar Cancer. Front Oncol. 2017 Sep 20;7:224.

Lu JJ, Brady LW, editors. Decision Making in Radiation Oncology [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 2011 [cited 2019 Dec 9]. (Medical Radiology; vol. 0). Available from: http://link.springer.com/10.1007/978-3-642-13832-4

Gaffney DK, King B, Viswanathan AN, Barkati M, Beriwal S, Eifel P, et al. Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 2016 Jul;95(4):1191–200.

Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al., editors. AJCC Cancer Staging Manual [Internet]. Cham: Springer International Publishing; 2017 [cited 2019 Dec 9]. Available from: http://link.springer.com/10.1007/978-3-319-40618-3

Reade CJ, Eiriksson LR, Mackay H. Systemic therapy in squamous cell carcinoma of the vulva: Current status and future directions. Gynecologic Oncology. 2014 Mar;132(3):780–9.

Nandwani P, Vyas R, Neema J, Suryanarayan U, Bhavsar D, Jani K. Retrospective analysis of role of interstitial brachytherapy using template (MUPIT) in locally advanced gynecological malignancies. J Can Res Ther. 2007;3(2):111.




DOI: https://doi.org/10.32532/jori.v11i2.112 <

Article metrics

Abstract views : 374 | views : 306

Refbacks

  • Saat ini tidak ada refbacks.




  

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.